Financials data is unavailable for this security.
View more
Year on year Immunocore Holdings PLC had net income fall 5.22% from a loss of 52.54m to a larger loss of 55.29m despite a 43.05% increase in revenues from 174.36m to 249.43m.
Gross margin | 99.38% |
---|---|
Net profit margin | -15.89% |
Operating margin | -23.24% |
Return on assets | -5.71% |
---|---|
Return on equity | -12.85% |
Return on investment | -7.45% |
More ▼
Cash flow in USDView more
In 2023, Immunocore Holdings PLC increased its cash reserves by 9.98%, or 40.15m. Cash Flow from Financing totalled 34.35m or 13.77% of revenues. In addition the company generated 2.94m in cash from operations while cash used for investing totalled 5.43m.
Cash flow per share | -0.8914 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 7.55 |
---|---|
Tangible book value per share | 7.55 |
More ▼
Balance sheet in USDView more
Current ratio | 3.78 |
---|---|
Quick ratio | 3.76 |
Total debt/total equity | 1.16 |
---|---|
Total debt/total capital | 0.5373 |
More ▼